Mandate

Vinge has advised VNV Global AB (publ) in connection with a directed share issue

February 19, 2021 Capital Markets and Public M&A

Vinge has advised VNV Global AB (publ), an investment company listed on Nasdaq Stockholm, in connection with a directed share issue whereby VNV Global receives approximately SEK 1,166 million in issue proceeds.

The subscription price was determined to SEK 100 per share through an accelerated book building process. The share issue was directed to selected Swedish and international investors. The company intends to use the expected net proceeds from the transaction to take advantage of investment opportunities in the near term, deploying capital in both existing investments in need of further growth capital and in to a pipeline of potential new investment opportunities.

VNV Global is an investment company with the business concept of using experience, expertise and a widespread network to identify and invest in assets with considerable potential for value appreciation. The company has a special focus on online marketplaces and businesses with strong network effects. The common shares of VNV Global are listed on Nasdaq Stockholm, Mid Cap segment, with the ticker VNV.

Vinge’s team consisted of Jesper Schönbeck, Joel Wahlberg and Eléonore Friberg.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026